NASDAQ : YI
111, Inc. — Key statistics
Healthcare · Medical Distribution · China
Last price 2.85 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 25.07M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 25.07M |
| Enterprise Value | 14.28M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 8.80M |
| Shares Change (YoY) | +1.50% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 42.25% |
| Owned by Institutions (%) | 0.39% |
| Float | 4.65M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | n/a |
| PB Ratio | 1.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.07 |
| Quick Ratio | 0.38 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.30 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -27.53% |
| Return on Assets (ROA) | -1.34% |
| Return on Invested Capital (ROIC) | -5.86% |
| Return on Capital Employed (ROCE) | -24.95% |
| Weighted Average Cost of Capital (WACC) | 9.13% |
| Revenue Per Employee | $1.45M |
| Profits Per Employee | -$14,593 |
| Employee Count | 1,063 |
| Asset Turnover | 4.92 |
| Inventory Turnover | 9.35 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -35.08% |
| 50-Day Moving Average | 3.32 |
| 200-Day Moving Average | 5.08 |
| Relative Strength Index (RSI) | 32.73 |
| Average Volume (20 Days) | 16,473 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4,313 |
| Short Previous Month | 7,014 |
| Short % of Shares Out | 0.08% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.27 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.54B |
| Gross Profit | 46.35M |
| Operating Income | -6.75M |
| Pretax Income | -9.77M |
| Net Income | -15.51M |
| EBITDA | -5.38M |
| EBIT | -6.75M |
| Loss Per Share | -$1.77 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 52.30M |
| Total Debt | 41.51M |
| Net Cash | 10.79M |
| Net Cash Per Share | $1.23 |
| Equity (Book Value) | 23.48M |
| Book Value Per Share | -12.95 |
| Working Capital | 17.35M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.29M |
| Capital Expenditures | -669,374 |
| Depreciation & Amortization | 1.40M |
| Net Borrowing | 4.01M |
| Free Cash Flow | -5.96M |
| FCF Per Share | -$0.68 |
Margins
| Measure | Value |
|---|
| Gross Margin | 3.00% |
| Operating Margin | -0.44% |
| Pretax Margin | -0.63% |
| Profit Margin | -1.01% |
| EBITDA Margin | -0.35% |
| EBIT Margin | -0.44% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.50% |
| Shareholder Yield | -1.50% |
| Earnings Yield | -62.05% |
| FCF Yield | -23.79% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.83 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |